7IJR
Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0208 (Mac1-x10313)
This is a non-PDB format compatible entry.
Summary for 7IJR
| Entry DOI | 10.2210/pdb7ijr/pdb |
| Group deposition | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group (G_1002351) |
| Descriptor | Non-structural protein 3, (1R,2R)-2-(isoquinolin-6-yl)cyclopentane-1-carboxylic acid, DIMETHYL SULFOXIDE, ... (4 entities in total) |
| Functional Keywords | diamond i04-1, pandda, xchemexplorer, crystallographic fragment screening, sars-cov-2, macrodomain, viral protein |
| Biological source | Severe acute respiratory syndrome coronavirus 2 |
| Total number of polymer chains | 2 |
| Total formula weight | 36676.95 |
| Authors | Aschenbrenner, J.C.,Watt, G.,Marples, P.G.,Wang, X.,Schuller, M.,O'Brien, P.,Fearon, D.,von Delft, F. (deposition date: 2025-08-04, release date: 2025-08-13) |
| Primary citation | Aschenbrenner, J.C.,Watt, G.,Marples, P.G.,Wang, X.,Donald, J.R.,Butler, W.T.W.,Shaw, A.,Schuller, M.,O'Brien, P.,Fearon, D.,von Delft, F. Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published, |
| Experimental method | X-RAY DIFFRACTION (1.206 Å) |
Structure validation
Download full validation report






